AJP - Regulatory, Integrative and Comparative Physiology, Vol 268, Issue 4 997-1002, Copyright © 1995 by American Physiological Society

ARTICLES

Effects of Ca2+ ionophore ionomycin on insulin-stimulated and basal glucose transport in muscle

A. D. Lee, E. A. Gulve, M. Chen, J. Schluter and J. O. Holloszy
Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

There is evidence that an increase in sarcoplasmic Ca2+ stimulates glucose transport in muscle. Recent studies have provided the apparently conflicting finding that a sustained increase in cytosolic Ca2+ has little effect on basal glucose transport but inhibits insulin-stimulated transport. This study was done to try to explain this discrepancy. Continuous exposure of rat epitrochlearis and soleus muscles to the Ca2+ ionophore ionomycin (2 microM) had no effect on basal 2-deoxyglucose (2-DG) transport but blunted, by approximately 40%, stimulation of 2-DG transport by insulin. Decreasing Ca2+ in the medium to a very low level prevented this inhibition. Ionomycin induced a small increase in adenosine 3',5'-cyclic monophosphate (cAMP); however, studies with the protein kinase A (PKA) inhibitor HA-1004 provided evidence that activation of PKA by cAMP does not mediate the inhibition of glucose transport. When muscles were allowed to recover in the absence of ionomycin for 15 min, basal 2-DG transport was significantly increased. Our results agree with previous studies showing that a sustained influx of Ca2+ into the cytoplasm can inhibit insulin-stimulated glucose transport. They further show that stimulation of glucose transport by Ca2+ is also inhibited. A recovery period that allows this inhibition to wear off unmasks the stimulation of glucose transport by an increase in sarcoplasmic Ca2+.

This article has been cited by other articles:

				A. J. Rose and E. A. Richter Skeletal Muscle Glucose Uptake During Exercise: How is it Regulated? Physiology, August 1, 2005; 20(4): 260 - 270. [Abstract] [Full Text] [PDF]

				M. A. FEBBRAIO and B. K. PEDERSEN Muscle-derived interleukin-6: mechanisms for activation and possible biological roles FASEB J, September 1, 2002; 16(11): 1335 - 1347. [Abstract] [Full Text] [PDF]

				T. D. Ardizzone, X.-H. Lu, and D. S. Dwyer Calcium-independent inhibition of glucose transport in PC-12 and L6 cells by calcium channel antagonists Am J Physiol Cell Physiol, August 1, 2002; 283(2): C579 - C586. [Abstract] [Full Text] [PDF]

				R. Bergeron, R. R. Russell III, L. H. Young, J.-M. Ren, M. Marcucci, A. Lee, and G. I. Shulman Effect of AMPK activation on muscle glucose metabolism in conscious rats Am J Physiol Endocrinol Metab, May 1, 1999; 276(5): E938 - E944. [Abstract] [Full Text] [PDF]

				T. Hayashi, J. F. P. Wojtaszewski, and L. J. Goodyear Exercise regulation of glucose transport in skeletal muscle Am J Physiol Endocrinol Metab, December 1, 1997; 273(6): E1039 - E1051. [Abstract] [Full Text] [PDF]

				J. P. Whitehead, J. C. Molero, S. Clark, S. Martin, G. Meneilly, and D. E. James The Role of Ca2+ in Insulin-stimulated Glucose Transport in 3T3-L1 Cells J. Biol. Chem., July 20, 2001; 276(30): 27816 - 27824. [Abstract] [Full Text] [PDF]